International audienceOBJECTIVES: We report a first experience involving the use of (90)Y radiolabelled microspheres (TheraSphere) for the treatment of mainly primary hepatic tumours. MATERIALS AND METHODS: Treatment using TheraSphere microspheres was planned in 15 patients (13 with hepatocellular carcinoma, 2 with neuroendocrine tumour metastases). The treatment was preceded by a first angiography aimed at embolizing the vascularizing arterial branches of other structures outside the liver and evaluating the percentage of pulmonary shunt by scintiscanning after perfusion with (99m)Tc-MAA. The objective of the treatment carried out during a second angiography was to deliver a dose of 120+/-20 Gy (mean+/-SD) to the target hepatic volume. RES...
BACKGROUND: Neuroendocrine liver metastases are clinically challenging due to their frequent dissemi...
Metastatic tumours of the liver are responsible for significant morbidity and mortality, and only a ...
International audienceLiver malignancies, either primary tumours (mainly hepatocellular carcinoma an...
Background/Aim: Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. R...
he relatively greater arteriolardensity in hepatic tu mors, both primaryand metastatic, compared to ...
AbstractBackground/AimHepatocellular carcinoma (HCC) is the most common primary malignancy of the li...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
PURPOSE Radioembolization with yttrium-90 microsphere (Y-90) therapy with SIR-Spheres (R) (Sirtex Me...
The term transarteria radioembolisation includes those procedures in which intra-arterially injected...
Inert microspheres, labeled with several radionuclides, have been developed during the last two deca...
AbstractRadioembolization (RE) is a selective internal radiotherapy technique in which yttrium-90 bl...
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In...
Radioembolization is a therapy during which radioactive microspheres are administered through a micr...
International audienceYttrium-90 (Y90) radioembolization is an emerging strategy to treat liver mali...
Inert microspheres, labeled with several radionuclides, have been developed during the last two deca...
BACKGROUND: Neuroendocrine liver metastases are clinically challenging due to their frequent dissemi...
Metastatic tumours of the liver are responsible for significant morbidity and mortality, and only a ...
International audienceLiver malignancies, either primary tumours (mainly hepatocellular carcinoma an...
Background/Aim: Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. R...
he relatively greater arteriolardensity in hepatic tu mors, both primaryand metastatic, compared to ...
AbstractBackground/AimHepatocellular carcinoma (HCC) is the most common primary malignancy of the li...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
PURPOSE Radioembolization with yttrium-90 microsphere (Y-90) therapy with SIR-Spheres (R) (Sirtex Me...
The term transarteria radioembolisation includes those procedures in which intra-arterially injected...
Inert microspheres, labeled with several radionuclides, have been developed during the last two deca...
AbstractRadioembolization (RE) is a selective internal radiotherapy technique in which yttrium-90 bl...
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In...
Radioembolization is a therapy during which radioactive microspheres are administered through a micr...
International audienceYttrium-90 (Y90) radioembolization is an emerging strategy to treat liver mali...
Inert microspheres, labeled with several radionuclides, have been developed during the last two deca...
BACKGROUND: Neuroendocrine liver metastases are clinically challenging due to their frequent dissemi...
Metastatic tumours of the liver are responsible for significant morbidity and mortality, and only a ...
International audienceLiver malignancies, either primary tumours (mainly hepatocellular carcinoma an...